辉瑞(PFE.US)卫生事件疫苗试验尚未达到首次分析免疫效果门槛
© Reuters. 辉瑞(PFE.US)卫生事件疫苗试验尚未达到首次分析免疫效果门槛
智通财经APP获悉，周二，辉瑞(PFE.US)表示，该公司开展的针对卫生事件疫苗大规模后期试验尚未达到可分析免疫效果的程度。这家制药商三季度业绩演示显示，监督试验进展的数据监控委员会尚未对疫苗效果进行期中分析。
这意味着受试者中的卫生事件感染病例不足32例。该公司疫苗试验将展开四次效果分析，首次分析的门槛是达到32例。辉瑞的卫生事件疫苗试验招募了逾4.2万名受试者。该公司周二表示，截至10月26日，已有近3.6万人接种第二剂。
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
If you like, reward to support.
Hot
-THE END-